# Filing Detail

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0000906709-23-000004
Filing Date
2023-02-28
Accepted
2023-02-28 16:48:43
Documents
93
Period of Report
2022-12-31

Document Format Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
1 | 10-K | nktr-20221231.htm iXBRL | 10-K | 2149347
2 | EX-21.1 | nktr20221231-exx211.htm | EX-21.1 | 1351
3 | EX-23.1 | nktr20221231-exx231.htm | EX-23.1 | 5822
4 | EX-31.1 | nktr-20221231xexx311.htm | EX-31.1 | 8113
5 | EX-31.2 | nktr-20221231xexx312.htm | EX-31.2 | 8116
6 | EX-32.1 | nktr-20221231xexx321.htm | EX-32.1 | 6349
12 |  | nktr-20221231_g1.jpg | GRAPHIC | 308646
| Complete submission text file | 0000906709-23-000004.txt |  | 10496423

Data Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
7 | XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT | nktr-20221231.xsd | EX-101.SCH | 77602
8 | XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT | nktr-20221231_cal.xml | EX-101.CAL | 108062
9 | XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT | nktr-20221231_def.xml | EX-101.DEF | 322885
10 | XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT | nktr-20221231_lab.xml | EX-101.LAB | 847302
11 | XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT | nktr-20221231_pre.xml | EX-101.PRE | 553216
87 | EXTRACTED XBRL INSTANCE DOCUMENT | nktr-20221231_htm.xml | XML | 1548372

Mailing Address 455 MISSION BAY BOULEVARD SOUTH SAN FRANCISCO CA 94158
Business Address 455 MISSION BAY BOULEVARD SOUTH SAN FRANCISCO CA 94158 4154825300
NEKTAR THERAPEUTICS (Filer) CIK: 0000906709 (see all company filings)

EIN.: 943134940 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 000-24006 | Film No.: 23686584
SIC: 2834 Pharmaceutical Preparations